Zobrazeno 1 - 10
of 198
pro vyhledávání: '"E. Malta"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E. Malta, F. Jiritano, Giuseppe Filiberto Serraino, Giuseppe Musolino, A. di Virgilio, P. Mastroroberto, C. Garrasi
Publikováno v:
Journal of Cardiovascular Medicine. 19:e77
Autor:
E. Malta
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. :236-243
The concentration-effect curve for the relaxant effects of glyceryl trinitrate (GTN) in rat aortic rings consisted of two phases with IC50 values of 0.1 microM for Phase I and 14 microM for Phase II. Incubation of tissues with oxyhaemoglobin or the i
Autor:
Michael Sendtner, Marcus Beck, Richard D. Penn, Jörg C. Tonn, Ralf Giess, G. Ochs, Michelle M. York, E Malta, Klaus V. Toyka, Jeremy Haigh, Michael Traub
Publikováno v:
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 1:201-206
Brain derived neurotrophic factor (BDNF) is a potent survival factor for motoneurons. This study investigated the safety and tolerability of recombinant methionyl human BDNF (r-metHuBDNF) infused intrathecally by means of an implanted pump in patient
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E.Themis Joannides, Josephine C. Sesnie, Carl L. Heifetz, Thomas E. Malta, Martin A. Shapiro, Julie A. Dever
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 36:185-187
A relatively simple, rapid throughput phototolerance screen in small animals would be very useful in early drug development. It could prioritize or select potential lead compounds from among a number of analogs with similar biological activities. Thi
Publikováno v:
Journal of the neurological sciences. 169(1-2)
The ALS Functional Rating Scale (ALSFRS) is a validated rating instrument for monitoring the progression of disability in patients with amyotrophic lateral sclerosis (ALS). One weakness of the ALSFRS as originally designed was that it granted disprop
Autor:
E, Malta
Publikováno v:
Advances in neurology. 68
These are but a few of the controversies and pressures facing Sponsors of clinical trials in ALS. All researchers in the area share the hope that the current level of interest in clinical trials in ALS will lead to the development of effective therap
Publikováno v:
Biopharmaceuticsdrug disposition. 14(7)
We investigated the effect of albumin (6%) on the (+/-)-isoprenaline-induced relaxation of strips of isolated rat uterus and its antagonism by (-)-propranolol. The mean isoprenaline EC50 in the presence of albumin was significantly less than that in
Publikováno v:
European journal of pharmacology. 196(2)
Cultured endothelial cells from bovine thoracic aortas conditioned with serum-free culture media released an endothelin-1 (ET)-1-like substance. Concentrations of ET-1-like material were determined by bioassay as contractions of isolated ring segment